The FDA hit API manufacturer Intas Pharmaceuticals over inadequate test records, water quality and other violations.
Source: Drug Industry Daily
The FDA hit API manufacturer Intas Pharmaceuticals over inadequate test records, water quality and other violations.
Source: Drug Industry Daily